The Animal Models for Dengue Virus Infection
|
|
- Antony Ryan
- 6 years ago
- Views:
Transcription
1 Tao Peng, Junlei Zhang and Jing An # Department of Microbiology, College of Medicine, Third Military Medical University, Chongqing, , People s Republic of China Abstract Currently, the mechanisms involved in the pathogenesis of DHF/DSS remain poorly understood and there is no effective vaccine available to prevent infection with DEN virus. The lack of a reliable small animal model that mimics dengue disease is a major obstacle. In this paper, the development of small animal models such as mice for dengue virus infections is reviewed. Keywords: Dengue virus, animal model, mice. Introduction Dengue (DEN) viruses are mosquito-borne RNA viruses, which belong to the genus Flavivirus (family Flaviviridae), and are grouped into four antigenically distinct types (DEN-1, DEN-2, DEN-3, and DEN-4). Every year, they infect millions of people and can cause a mild-to-debilitating febrile illness (classical dengue fever, DF) or lifethreatening syndrome (dengue haemorrhagic fever/dengue shock syndrome, DHF/DSS). In recent years, the geographical range of dengue in tropical and subtropical regions of the world has extended and DHF/DSS is occurring in new areas and with increased incidence [1]. Cardinal signs of DHF/DSS include haemorrhage, abrupt onset of vascular leakage and shock, accompanied by severe thrombocytopenia and massive complement activation. However, the mechanisms involved in the pathogenesis of DHF/DSS remain poorly understood and there is no effective vaccine available to prevent infection with any of the four serotypes of DEN virus. A major technical barrier is the absence of a suitable animal model that mimics DEN disease, including DHF/DSS. So far, there are only three known hosts for DEN virus infections: mosquitoes, humans and lower primates [2]. Although these lower primates infected with wild type DEN viruses develop viremia, they generally manifest only very mild or no clinical signs of disease [3]. Since the appearance of the severe combined immunodeficiency (SCID) mice in 1983 [4], efforts have been made to develop new small animal models that may be useful for the development of a future DEN virus vaccine and for studying the pathogenesis of DEN virus infections. # anjing60@yahoo.com.cn; Tel.: ; Fax: Dengue Bulletin Vol 28, 2004
2 Animal models based on SCID mice The SCID mice, which do not produce functional T and B cells and lack detectable immunoglobulin (Ig), can support DEN - susceptible human cell lines xenografts, and this system has been employed to study DEN virus infection in vivo. SCID mice reconstituted with human peripheral blood lymphocytes (hu-pbl-scid) have been used for studies on the pathogenesis of infection with the human immunodeficiency virus (HIV) [5,6] and for research on treatment of HIV infection [7]. The hu-pbl-scid mice were firstly evaluated as an animal model for DEN viral infection in 1995 [8]. SCID mice were injected intraperitoneally (ip) with hu-pbl for reconstitution and successful engraftment was demonstrated by the presence of a high serum level of human IgG. Hu-PBL-SCID mice were ip-infected with DEN-1 virus. Unfortunately, only 5 of 19 hu-pbl-scid mice showed sensitivity to DEN-1 virus. It was suggested that the main reason for the low DEN infection rate was a scanty number of appropriate human target cells in the reconstituted mice. Thus, investigators searched for more DEN-susceptible human cell lines to improve the infection rate of the SCID mouse model. One promising candidate was K562 cell, an erythroleukemia cell line. SCID mice were engrafted ip with K562 cells (K562-SCID mice) [9]. After intratumor injection into the peritoneal tumor masses of DEN-2 virus, K562-SCID mice showed neurological signs of paralysis and died at approximately 2 weeks post-infection (pi). In addition to being detected in the tumour masses, high virus titers were detected in the peripheral blood and the brain tissues, indicating that DEN virus had replicated in the infected K562-SCID mice. Other serotypes of DEN viruses were also used to infect the K562- SCID mice, and the mortality rates of the infected mice varied with different challenge strains, suggesting that this animal system might potentially be utilized to define the virulence of various human DEN isolates and to characterize the molecular determinants for such viral virulence. K562- SCID mice were also challenged with DEN - 2 virus and received antibody administration at the same time or one day earlier, and the results revealed that these mice exhibited a reduction in mortality and a delay of paralysis onset after DEN virus infection. These results indicated that an in vitro neutralizing antibody also defended K562- SCID mice against DEN-2 virus infection. Target cells and organs for DEN virus replication in humans remain unclear. Unusual clinical manifestations, mostly cerebral and hepatic symptoms, have become more common in patients with DEN virus infection in recent years [10,11]. The involvement of liver cells in the pathogenesis of DEN virus infection has been indicated by abnormal liver function, pathological findings and detection of viral antigen in hepatocytes and Kupffer s cells at biopsies [12]. It was reported that DEN virus could replicate in a human heptocarcinoma cell line, HepG2, and infectious particles were released into the culture medium [13,14]. Therefore, HepG2 cells were transplanted into SCID mice to develop an animal model for studying the pathogenesis of DEN virus infection [15]. The replication of HepG2 cells in host mice was confirmed by an increase of serum human albumin and propagation of HepG2 cells in the liver. At 7-8 weeks Dengue Bulletin Vol 28,
3 after transplantation, HepG2-grafted SCID mice were ip-infected with DEN-2 virus. A high titer of the virus was detected in the liver and serum but not in the brain in the early stage of the infection. When the mice showed paralysis, the highest titer of virus was detected in the serum and brain. DEN - 2 antigens were also found in HepG2 cells of the liver in the early stage and some neurons of the brain in the late stage. Upon clinical examination, thrombocytopenia, prolonged partial thromboplastin time, increased haematocrit, blood urea nitrogen and tumour necrosis factor a (TNF a) were seen in the paralyzed mice. Moreover, mild haemorrhages in the liver and tarry stool in the small intestine were observed in some mice. All of above animal models based on SCID mice with transplanted DEN - susceptible human cells mimic some of the aspects of human disease, which may be helpful for studying DEN virus infection, especially in the areas of viral pathogenesis, virus-host interaction and vaccine development against DEN infections. However, it is generally agreed that DHF/DSS is an immune-mediated disease, and since SCID mice are unable to produce the innate immune response, this may impose some limitations on the use of these animal models to extrapolate the situation in human DHF/DSS. BALB/c mouse model Inbred four-week-old BALB/c mice were found sensitive (haplotype H-2d) to the challenge with dengue virus type 2 (strain P23085) [16]. Mice were ip-infected with a dose of 5 LD 50 of the mouse-adapted DEN - 2 virus, and the first clinical manifestations such as arching of the back, ruffling of the fur and slowing of activity appeared at end of day 4 pi. The presence of DEN-2 virus in the blood was confirmed on day 2 pi by reverse transcriptase-polymerase chain reaction (RT-PCR). The development of the experimental DEN -2 virus infection in mouse model was accompanied by the virus reproduction in all animals. Within 5 and 6 days pi, all mice showed severe sickness with anorexia and weight loss ending in limb paralysis and 100% mortality rate was noted at 7 days pi. The most impressive changes were seen with TNF-a, which abruptly and steeply increased 24 h before death. Serum levels of interleukin (IL)-1ß, IL- 6, IL-10, IL-1 receptor antagonist and soluble TNF receptor I continuously increased during the time of infection. Treating animals with anti-tnf-a serum reduced the mortality rate down to 40%. This model supports the view that the activation of innate immune response is at least partially responsible for mortality in DEN-2 virus infection, and in line with this concept, anti-tnf treatment significantly reduces the mortality rates. Therefore, inbred 4-week-old BALB/c mice are useful models to research the immune activation of host in DEN-2 virus infection. Gene knockout mouse (AG129) model There is evidence that alpha and beta interferons (IFN-a/ß) and gamma IFN (IFN-?) might be involved in human DEN virus infection [17,18]. In addition, exogenously administered IFN appears to protect mice from DEN virus challenge [19]. This information suggested that mice defective in their IFN response might provide a suitable 170 Dengue Bulletin Vol 28, 2004
4 model for DEN virus infection. Intraperitoneally administered mouseadapted DEN -2 virus was uniformly lethal in AG129 mice [20], which lack IFN-a/ß and IFN-? receptor genes, regardless of age. The mice showed neurological abnormalities, including hind-leg paralysis and blindness at 7 days pi, and died at 12 days after infection. The immunized mice were protected from virus challenge, and the survival time increased following passive transfer of anti- DEN polyclonal antibody. To determine which aspect of the IFN response was critical in protecting these mice from DEN virus infection, animals individually deficient in either IFN-a/ß (A129) or IFN-? (GKO) functions as well as BALB/c controls were subjected to a similar DEN virus challenge. None of these mice exhibited any overt symptoms of illness, indicating that for DEN virus infection, IFN-a, -ß, and -? abnormalities in combination were necessary for the mouse-adapted virus to be lethal when the ip challenge route was used. These results demonstrated that AG129 mice were a promising small animal model for DEN virus vaccine trials. A/J mouse model DEN virus infection causes DF and DHF/DSS. No animal model is available that mimics this clinical manifestation. The immunocompetent mouse (A/J strain) was reported as a mouse model for DEN virus infection that resembles the thrombocytopenia manifestation [21]. Intravenous injection of DEN-2 virus into A/J mice induced paraplegia at 2-3 weeks, while the mock-infected controls were normal. Viremia detected by RT-PCR was found transiently at two days but at no other time after infection. Although A/J mice developed paraplegia after virus infection, they recovered after one month. However, there was transient thrombocytopenia at days pi. When the mice were re-infected with the same DEN-2 virus two months later, thrombocytopenia was manifested again at 10 days after infection. Anti-platelet antibody was also generated after injection. And there was strain variation in DEN-2 virus infection; the A/J strain was more sensitive than BALB/c or B6 mice. These results show that this DEN-2 virus-infected mouse system accompanied by thrombocytopenia and anti-platelet antibody may be a suitable model to study the pathogenicity, especially immune activation in DEN virus infection. On the other hand, A/J mice had to be inoculated with a large quantity of DEN-2 virus; a dose of less than pfu per mouse was not effective in causing paraplegia. Furthermore, viremia was low and transient in A/J mice compared with that in SCID or IFN-deficient AG129 mice. DEN-2 virus could not be isolated from the blood of infected mice; it could only be detected by sensitive RT-PCR in A/J mice. Conclusion Although the above-mentioned new small animal models, which mimic some of the aspects of human DEN virus disease, may facilitate not only the study of DEN pathogenesis but also the evaluation of anti- DEN virus as well as vaccine development, there are still drawbacks in each model, especially in mimicing DHF/DSS. Presently, the molecular mechanisms underlying the pathogenesis of DHF/DSS remain unknown, such as the receptors of DEN virus which are still not clear. Even though the use of transgenic animals has been proposed in the quest for an animal model, it is apparent Dengue Bulletin Vol 28,
5 that one needs to know more about the mechanisms involved in the pathogenesis of DHF/DSS at the molecular level before one can construct a transgenic animal to serve as a model for use in research on the pathogenesis, vaccine development and therapy for DHF/DSS. Acknowledgment This work was partially supported by grants nos and from the National Science Foundation of China (NSFC). References [1] Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, Ramos C, Boshell J, de Mesa MT, Nogueira RM and da Rosa AT. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology, 1997, 230: [2] Gubler DJ. Dengue viruses. In R.G. Webster and A. Granoff (Eds.), Encyclopedia of virology. Academic Press, Inc., San Diego, California, 1994: [3] Schlesinger RW. Dengue virus. New York, Spriger-Verlag, 1977: [4] Bosma GC, RP Custer and MJ Bosma. A severe combined immunodeficiency mutation in the mouse. Nature, 1983, 301: [5] Mosier DE. Immunodeficient mice xenografted with human lymphoid cells: new models for in vivo studies of human immunobiology and infectious diseases. Journal of Clinical Immunology, 1990, 10: [6] Mosier DE. Viral pathogenesis in hu-pbl- SCID mice. Seminars in Immunology, 1996, 8: [7] McCune JM, Namikawa R, Shih CC, Rabin L and Kaneshima H. Suppression of HIV infection in AZT-treated SCID-hu mice. Science, 1990, 247: [8] Wu S-JL, Hayes CG, Dubois DR, Windheuser MG, Kang Y-H, Watts DM and Sieckmann DG. Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection. The American Journal of Tropical Medicine and Hygiene, 1995, 52: [9] Lin YL, Liao CL, Chen LK, Yeh CT, Liu CI, Ma SH, Huang YY, Huang YL, Kao CL and King CC. Study of dengue virus infection in SCID mice engrafted with human K562 cells. Journal of Virology, 1998, 72: [10] Rajajee S and Mukundan D. Neurological manifestations in dengue hemorrhagic fever. Indian Pediatrics, 1994, 31: [11] Thisyakorn U and Thisyakorn C. Dengue infection with unusual manifestations. Journal of the Medical Association of Thailand, 1994, 77: [12] Kuo CH, Tai DI, Chien CSC, Lan CK, Chiou SS and Liaw YF. Liver biochemical tests and dengue fever. The American Journal of Tropical Medicine and Hygiene, 1992, 47: [13] Marianneau P, Megret F, Olivier R, Morens DM and Deubel V. Dengue 1 virus binding to human hepatoma HepG2 and simian Vero cell surface differs. Journal of General Virology, 1996, 77: [14] Marianneau P, Cardona A, Edelman L, Deubel V and Despres P. Dengue virus replication in human hepatoma cells activates NF-kB which in turn reduces apoptotic cell death. Journal of Virology, 1997, 71: Dengue Bulletin Vol 28, 2004
6 [15] An J, Kimura-Kuroda J, Hirabayashi Y and Yasui K. Development of a novel mouse model for dengue virus infection. Virology, 1999, 263: [16] Atrasheuskaya A, Petzelbauer P, Fredeking TM and Ignatyev G. Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection. FEMS Immunology and Medical Microbiology, 2003, 35: [17] Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janus J and Ennis FA. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in the sera of children with dengue. Journal of Clinical Investigation, 1991, 88: [18] Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A and Ennis FA. High levels of interferon alpha in the sera of children with dengue virus infection. The American Journal of Tropical Medicine and Hygiene, 1993, 48: [19] Cole GA and Wisseman CL Jr. Pathogenesis of type 1 dengue virus infection in suckling, weanling and adult mice. 1. The relation of virus replication to interferon and antibody formation. American Journal of Epidemiology, 1969, 89: [20] Johnson AJ and Roehrig JT. New mouse model for dengue virus vaccine testing. Journal of Virology, 1999, 73: [21] Huang K-J, Li S-YJ, Chen S-C, Liu H-S, Lin YS, Yeh T-M, Liu C-C and Lei H-Y. Manifestation of thrombocytopenia in dengue-2-virus-infected mice. Journal of General Virology, 2000, 81: Dengue Bulletin Vol 28,
Immunopathogenesis of Dengue Hemorrhagic Fever
Immunopathogenesis of Dengue Hemorrhagic Fever Carlos A. Sariol, MD, MS. Associated Investigator School of Medicine, MSC-UPR September 17th, 2009 Foro Educativo para Maestros de Ciencias en la UPRH September
More informationOlarn Prommalikit 1, Woraman Waidab 2, Kanya Suphapeetiporn 3 and Usa Thisyakorn 3
CYTOKINE-RELATED GENE EXPRESSION IN PERIPHERAL BLOOD LEUKOCYTES AND DENGUE INFECTION SEVERITY Olarn Prommalikit 1, Woraman Waidab 2, Kanya Suphapeetiporn 3 and Usa Thisyakorn 3 1 Department of Pediatrics,
More informationDENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT
DENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT Usa Thisyakorn and Chule Thisyakorn Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Abstract. Dengue has spread
More informationManifestation of thrombocytopenia in dengue-2-virus-infected mice
Journal of General Virology (2000), 81, 2177 2182. Printed in Great Britain... Manifestation of thrombocytopenia in dengue-2-virus-infected mice Kao-Jean Huang, Shu-Yi J. Li, Shiour-Ching Chen, Hsiao-Sheng
More informationIN VIVO STUDIES ON VIRAL VIRULENCE
IN VIVO STUDIES ON VIRAL VIRULENCE M.Phil student: Emily TSUI Supervisor: Professor Paul K.S Chan Department of Microbiology, CUHK Date: 15th Dec, 2014 Viral Virulence Capacity of a virus to cause disease
More informationWhat is the role of animal models in studying protective titres and the need for establishing surrogates/correlates of protection?
What is the role of animal models in studying protective titres and the need for establishing surrogates/correlates of protection? Alan D.T. Barrett Department of Pathology and Sealy Center for Vaccine
More informationDengue Infection at Children's Hospital of Bangkok
Dengue Infection at Children's Hospital of Bangkok Principal Investigators : Robert McNair Scott, MAJ, MC Suchitra Nimmannitya, M.D.1 Pethai Mansuwan, M.D.1 Franklin H. Top, Jr., LTC, MC William H. Bancroft,
More informationDengue Haemorrhagic Fever in Taiwan
by Jien-Wei Liu*, Boon-Siang Khor*, Chen-Hsiang Lee*, Ing-Kit Lee*, Rong-Fu Chen** and Kuender D Yang** # *Division of Infectious Diseases, Department of Internal Medicine, Chang Gung Memorial Hospital-Kaohsiung,
More informationCirculating levels of tumour necrosis factor-α & interferon-γ in patients with dengue & dengue haemorrhagic fever during an outbreak
Indian J Med Res 123, January 2006, pp 25-30 Circulating levels of tumour necrosis factor-α & interferon-γ in patients with dengue & dengue haemorrhagic fever during an outbreak Anita Chakravarti & Rajni
More informationDengue Vaccine Butantan Institute. DCVMN, Bangkok, 2015
Dengue Vaccine Butantan Institute DCVMN, Bangkok, 2015 GENOME Dengue Viruses Dengue is a mosquito-borne RNA virus with 4 distinct serotypes: 1,2,3,and 4 3 structural proteins: C, prm, and E E protein is
More informationMedical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University
Medical Virology Immunology Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University Human blood cells Phases of immune responses Microbe Naïve
More informationDengue pathogenesis and vaccine design
Dengue pathogenesis and vaccine design Dengue 390 million cases worldwide each year Fever to severe hemorrhaging and shock No effective vaccine Tropical disease on the move Dengue disease worldwide WHO
More informationANTIBODIES DETERMINE VIRULENCE IN DENGUE. Scott B HALSTEAD, M.D. DIRECTOR, Research Pediatric Dengue Vaccine Initiative IVI, Seoul, Korea
ANTIBODIES DETERMINE VIRULENCE IN DENGUE Scott B HALSTEAD, M.D. DIRECTOR, Research Pediatric Dengue Vaccine Initiative IVI, Seoul, Korea Global Spread of Dengue 50-100 million infections/year Countries
More informationThe Features of Imported Dengue Fever Cases Confirmed at National Institute of Infectious Diseases Japan, during p
The Features of Imported Dengue Fever Cases Confirmed at National Institute of Infectious Diseases Japan, during 2001 +p by Ken-Ichiro Yamada* #, Tomohiko Takasaki*, Masaru Nawa**, Reiko Nerome*, Yohko
More informationDIAGNOSIS OF DENGUE INFECTION USING VARIOUS DIAGNOSTIC TESTS IN THE EARLY STAGE OF ILLNESS
DIAGNOSIS OF DENGUE INFECTION USING VARIOUS DIAGNOSTIC TESTS IN THE EARLY STAGE OF ILLNESS Rangsima Lolekha 1, Kulkanya Chokephaibulkit 1, Sutee Yoksan 2, Nirun Vanprapar 1, Wanatpreeya Phongsamart 1 and
More informationAnimal Models to Understand Immunity
Animal Models to Understand Immunity Hussein El Saghire hesaghir@sckcen.be Innate Adaptive immunity Immunity MAPK and NF-kB TLR pathways receptors Fast Slow Non-specific Specific NOD-like receptors T-cell
More informationNASRONUDIN 4/17/2013. DENVs of each type are grouped into several genotypes.
NASRONUDIN Institute of Tropical Disease, Airlangga University-Tropical and Infectious Diseases Division, Department of Internal Medicine Medical Faculty-Dr. Soetomo Hospital Disampaikan pada 14 th Jakarta
More informationDengue Haemorrhagic Fever in Thailand, : Primary or Secondary Infection
Dengue Haemorrhagic Fever in Thailand, 1998-2003: Primary or Secondary Infection by M Sriprom*, P Pongsumpun*, S Yoksan**, P Barbazan***, J P Gonzalez** and I M Tang +# *Department of Mathematics, Faculty
More informationMODULE 5. Dengue. Edwin J. Asturias Associate Professor of Pediatrics Senior Investigator Director for Latin America
MODULE 5 Dengue Edwin J. Asturias Associate Professor of Pediatrics Senior Investigator Director for Latin America Symptoms of Dengue Fever Dengue: Skin rashes DHF manifestations Hemorrhages Thrombocytopenia
More informationProduction of Interferon Alpha by Dengue Virus-infected Human Monocytes
J. gen. Virol. (1988), 69, 445-449. Printed in Great Britain 445 Key words: IFN-ct/dengue virus/monocytes Production of Interferon Alpha by Dengue Virus-infected Human Monocytes By ICHIRO KURANE AND FRANCIS
More informationRetrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000
J Microbiol Immunol Infect. 2008;41:377-385 Retrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000 Shu-Fen Chang 1, Jyh-Hsiung Huang
More informationCurrent Status of Dengue Diagnosis at the Center for Disease Control, Taiwan
Current Status of Dengue Diagnosis at the Center for Disease Control, Taiwan Pei-Yun Shu, Shu-Fen Chang, Yi-Yun Yueh, Ling Chow, Li-Jung Chien, Yu-Chung Kuo, Chien-Lin Su, Tsai-Ling Liao, Ting-Hsiang Lin
More information10th International Rotavirus Symposium Bangkok, Thailand
Rotavirus Host Range Restriction and Innate Immunity: Mechanisms of Vaccine Attenuation Harry Greenberg MD Stanford University 10th International Rotavirus Symposium Bangkok, Thailand 09/19/12 B dsrna
More informationChapter 24 The Immune System
Chapter 24 The Immune System The Immune System Layered defense system The skin and chemical barriers The innate and adaptive immune systems Immunity The body s ability to recognize and destroy specific
More informationMarmoset-based infectious disease research under biocontainment conditions
Marmoset-based infectious disease research under biocontainment conditions Jean Patterson, PhD Texas Biomedical Research Institute October 22 nd, 2018 West Nile virus Common marmoset found to be equivalently
More informationDOI: /ICJ poliovirus. [14] (Hand-Foot-Mouth Disease, HFMD) (Herpangina) 71 [26] [17,18,27] 71 picornaviridae
174 DOI: 10.6526/ICJ.2016.404 71 71 [14] (Hand-Foot-Mouth Disease, HFMD) (Herpangina) 71 71 picornaviridae poliovirus / 1990 71 [26] [17,18,27] 71 175 [31] ICR NOD/SCID AG129 hpsgl-1 hscarb2 (MP4) (MP4)
More information1. Dengue An Overview. Dengue Expert Advisory Group
1. Dengue An Overview Dengue Expert Advisory Group 1 Introduction Dengue Fever Dengue Hemorrhagic Fever Dengue Shock Syndrome 2 3 Dengue Virus Family : Flaviviridae Genus : Flavivirus Serotypes : DV1,
More informationDengue in Jeddah, Saudi Arabia,
by Mazen Fakeeh and Ali M Zaki Virus Laboratory, Dr Solimon Fakeeh Hospital, Jeddah, Saudi Arabia Abstract Dengue virus (DEN-2) was first isolated from a fatal case of dengue haemorrhagic fever (DHF) in
More informationPre-clinical Development of a Dengue Vaccine. Jeremy Brett Sanofi Pasteur, Singapore
Pre-clinical Development of a Dengue Vaccine Jeremy Brett Sanofi Pasteur, Singapore Dengue Vaccine B Guy 1 Talk flow Introduction: What are the challenges of dengue vaccine development? The Virus The host
More informationZika Virus Infection in Cynomolgus Macaques
Zika Virus Infection in Cynomolgus Macaques Fusataka Koide Program Leader, Emerging Pathogens Background Mosquito-borne virus belonging to the flavivirus genus of the Flaviviridae family. Dengue viruses,
More informationDOI: /ICJ (Dengue fever) [2] (Aedes aegypti) (Aedes albopictus) (Dengue. (Flavivirus) 50 nm. ssrna) (capsid, C) ( ) (membrane, prm/m)
210 DOI: 10.6526/ICJ.2016.504 T (Dengue fever) [1] 128 39 [2] 4 5 21,000 [3] 3 1981 1987 1995 2014 [4] 2015 ( ) (Aedes aegypti) (Aedes albopictus) (Dengue virus) (Flaviviridae) (Flavivirus) 50 nm 11 kb
More informationDengue Virus-Danger from Deadly Little Dragon
Molecular Medicine Dengue Virus-Danger from Deadly Little Dragon Dr.G.MATHAN Assistant Professor Department of Biomedical Science Bharathidasan University Tiruchirappalli, Tamil Nadu Vector (A carrier)
More informationUsa Thisyakorn and Chule Thisyakorn
CHILDHOOD DENGUE DISEASES: A TWENTY YEARS PROSPECTIVE STUDY Usa Thisyakorn and Chule Thisyakorn Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Abstract. Dengue
More informationInfectious Bursal Disease, Immunosuppression and the role of VAXXITEK HVT+ IBD
Research note Infectious Bursal Disease, Immunosuppression and the role of VAXXITEK HVT+ IBD Grogan K. 1 1 Poultry Chicken Scratch, LLC, 30019 Dacula GA United States of America [from Hoerr F.J., 2010,
More informationReplication Defective Enterovirus Infections: Implications for Type I Diabetes
Replication Defective Enterovirus Infections: Implications for Type I Diabetes N. M. Chapman Department of Pathology & Microbiology University of Nebraska Medical Center Enterovirus Genome and 2 Capsid
More informationComparison between serological & molecular methods for diagnosis of dengue fever and its correlation with duration of illness
Original article Comparison between serological & molecular methods for diagnosis of dengue fever and its correlation with duration of illness Prashant Gangurde, Anjali Swami, Jayanthi Shastri Name of
More informationNEUROLOGICAL MANIFESTATIONS IN DENGUE PATIENTS
NEUROLOGICAL MANIFESTATIONS IN DENGUE PATIENTS Chitsanu Pancharoen and Usa Thisyakorn Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Abstract. To determine the
More informationCategorisation of Dengue based on duration of fever and serological markers in a tertiary care hospital
Indian Journal of Basic and Applied Medical Research; June 27: Vol.-6, Issue- 3, P. 49-43 Original Article Categorisation of Dengue based on duration of fever and serological markers in a tertiary care
More informationA. Study Purpose and Rationale
IRB Proposal/CRC Rotation Sabrina J Gard, MD MPH Internal Medicine, PGY 1 5 May 2014 A. Study Purpose and Rationale Dengue is the most prevalent arthropod-transmitted virus, with conservative estimates
More informationSERUM FERRITIN LEVELS IN CHILDREN WITH DENGUE INFECTION
SERUM FERRITIN LEVELS IN CHILDREN WITH DENGUE INFECTION Wathanee Chaiyaratana 1, Ampaiwan Chuansumrit 2, Kalayanee Atamasirikul 3 and Kanchana Tangnararatchakit 2 1 Research Center, 2 Department of Pediatrics,
More informationNS1 Protein Expression in the JaOArS982 Strain of Japanese Encephalitis Virus Does Not Enhance Virulence in Mice
Tropical Medicine and Health Vol. 43 No.4, 2015, 233 237 doi: 10.2149/tmh.2015-27 Copyright 2015 by The Japanese Society of Tropical Medicine 233 Short Communications NS1 Protein Expression in the JaOArS982
More informationExchange Program. Thailand. Mahidol University. Mahidol-Osaka Center for Infectious Diseases (MOCID) Date: 2013/06/05~2013/07/04
Exchange Program Thailand Mahidol University Mahidol-Osaka Center for Infectious Diseases (MOCID) Date: 2013/06/05~2013/07/04 Kobe University School of Medicine Faculty of Health Science Ueda Shuhei Introduction
More informationIntroduction. Abstract
Comparison between Haemagglutination Inhibition (HI) Test and IgM and IgG-capture ELISA in Determination of Primary and Secondary Dengue Virus Infections Atchareeya A-nuegoonpipat a, Songthum Prakong a,
More informationZika Virus Basics. Flaviviridae Flavivirus Disease Vector Vaccine *Dengue (serotypes 1-4) Zika Virus Basics. Zika Virus Transmission Cycle
Zika: Infection,, and Protection Roxanne P. Liles, Ph.D., MLS(ASCP) CM Assistant Professor of Biology Louisiana State University at Alexandria 318-473-6518 rliles@lsua.edu Zika Virus Basics Virion: Enveloped
More informationMurine Model for Dengue Virus-Induced Lethal Disease with Increased Vascular Permeability
JOURNAL OF VIROLOGY, Oct. 2006, p. 10208 10217 Vol. 80, No. 20 0022-538X/06/$08.00 0 doi:10.1128/jvi.00062-06 Copyright 2006, American Society for Microbiology. All Rights Reserved. Murine Model for Dengue
More informationDengue NS1 Antigen - for Early Detection of Dengue Virus Infection
ORIGINAL ARTICLE Dengue NS1 Antigen - for Early Detection of Dengue Virus Infection Amol Hartalkar 1, Sheetal Hartalkar 2, Makarand Wani 3, Arvind Yadav 4 Associate Professor 1, Assistant Professor 2,
More informationViral Hepatitis Diagnosis and Management
Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents
More informationFayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES
1 of 7 I. Viral Origin. A. Retrovirus - animal lentiviruses. HIV - BASIC PROPERTIES 1. HIV is a member of the Retrovirus family and more specifically it is a member of the Lentivirus genus of this family.
More informationGlobal Perspectives on Dengue Research
By Scott B. Halstead Adjunct Professor, Department of Preventive Medicine, Uniformed Services, University of the Health Sciences, Bethesda, MD, USA Abstract Dengue viruses infect nearly 100 million human
More informationHepatitis virus immunity. Mar 9, 2005 Rehermann and Nascimbeni review Crispe review
Hepatitis virus immunity Mar 9, 2005 Rehermann and Nascimbeni review Crispe review HBV & HCV infection outcomes Both viruses cause immune-mediated active and chronic hepatitis HBV Vertical transmission
More informationLECTURE topics: 1. Immunology. 2. Emerging Pathogens
LECTURE 23 2 topics: 1. Immunology 2. Emerging Pathogens Benefits of the Normal Flora: 1. Protect us from colonization by other bacteria and fungi (competitive exclusion). 2. Many synthesize vitamins,
More informationGastroenteritis and viral infections
Gastroenteritis and viral infections A Large number of viruses are found in the human gut; these include some that are associated with gastroenteritis Rotaviruses Adenoviruses 40/41 Caliciviruses Norwalk-like
More informationImmune System. Name: Class: Date: Multiple Choice Identify the choice that best completes the statement or answers the question.
Class: Date: Immune System Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Which of the bacteria is the cause of pneumonia? a. staphylococci c. Treponema
More information3. Lymphocyte proliferation (fig. 15.4): Clones of responder cells and memory cells are derived from B cells and T cells.
Chapter 15 Adaptive, Specific Immunity and Immunization* *Lecture notes are to be used as a study guide only and do not represent the comprehensive information you will need to know for the exams. Specific
More informationJoseph E. Blaney, Jr.,* Jennifer M. Matro, Brian R. Murphy, and Stephen S. Whitehead
JOURNAL OF VIROLOGY, May 2005, p. 5516 5528 Vol. 79, No. 9 0022-538X/05/$08.00 0 doi:10.1128/jvi.79.9.5516 5528.2005 Recombinant, Live-Attenuated Tetravalent Dengue Virus Vaccine Formulations Induce a
More informationChapter - 1 INTRODUCTION
Chapter - 1 INTRODUCTION Page 1.1 Dengue Virus Structure and types of infection caused by the virus 2 1.2 WHO Classification of Dengue 4 1.3 Laboratory Diagnosis of Dengue 5 1.4 Aims and Objectives 9 1.5
More informationUNIVERSITI TEKNOLOGI MARA COPY NUMBER VARIATION OF FCGR3B GENE AMONG SEVERE DENGUE PATIENT IN MALAYSIA
UNIVERSITI TEKNOLOGI MARA COPY NUMBER VARIATION OF FCGR3B GENE AMONG SEVERE DENGUE PATIENT IN MALAYSIA UMI SHAKINA HARIDAN Thesis submitted in fulfilment of the requirements for the degree of Master of
More informationGeneration of IgM Anti-Platelet Autoantibody in Dengue Patients
Journal of Medical Virology 63:143±149 (2001) Generation of IgM Anti-Platelet Autoantibody in Dengue Patients Chiou-Feng Lin, 1 Huan-Yao Lei, 1 Ching-Chuan Liu, 2 Hsiao-Sheng Liu, 1 Trai-Ming Yeh, 3 Shan-Tair
More informationFlaviviruses New Challenges, New Vaccines
Flaviviruses New Challenges, New Vaccines Christian W. Mandl Institute of Virology Medical University of Vienna, AUSTRIA Family Flaviviridae Genus Hepacivirus Genus Pestivirus Genus Flavivirus (>70 members)
More informationHEPATITIS VIRUSES. Other causes (not exclusively hepatitis v.)also called sporadic hepatitis: HEPATITIS A(infectious hepatitis)
Dept.of Microbiology/Virology Assist.prof. Shatha F. Abdullah HEPATITIS VIRUSES Medically important hepatitis v. (liver)are: 1.HAV 2.HBV 3.HCV 4.HDV 5.HEV 6.HGV Other causes (not exclusively hepatitis
More informationEnvelope e_ :------, Envelope glycoproteins e_ ~ Single-stranded RNA ----, Nucleocapsid
Virus Antib(tdies Your Expertise, Our Antibodies, Accelerated Discovery. Envelope e_---------:------, Envelope glycoproteins e_-------1~ Single-stranded RNA ----, Nucleocapsid First identified in 1989,
More informationimmunity produced by an encounter with an antigen; provides immunologic memory. active immunity clumping of (foreign) cells; induced by crosslinking
active immunity agglutination allografts immunity produced by an encounter with an antigen; provides immunologic memory. clumping of (foreign) cells; induced by crosslinking of antigenantibody complexes.
More informationdengue virus DENV DENV-1 DENV-2 DENV-3 DENV-4 NS1 Non-structural protein 1 NS1 DENV antibody-dependent enhancement ADE DENV
2018 9 59 17 Journal of Traditional Chinese Medicine 2018 Vol. 59 No. 17 1523 DOI 10. 13288 /j. 11-2166 /r. 2018. 17. 021 1 1 dengue virus DENV A B C 2009 WHO 1 2014 2 3 2018 DENV 1 antibody-dependent
More informationDengue Fever: Its Laboratory Diagnosis, with Special Emphasis on IgM Detection
Dengue Fever: Its Laboratory Diagnosis, with Special Emphasis on IgM Detection by N Sathish, T S Vijayakumar, P Abraham and G Sridharan # Department of Clinical Virology, Christian Medical College, Vellore-632
More informationRESEARCH NOTE IDENTIFICATION OF DENGUE VIRUS IN AEDES MOSQUITOES AND PATIENTS SERA FROM SI SA KET PROVINCE, THAILAND
RESEARCH NOTE IDENTIFICATION OF DENGUE VIRUS IN AEDES MOSQUITOES AND PATIENTS SERA FROM SI SA KET PROVINCE, THAILAND Chai Teerasut 1, Udom Petphuwadee 1, Suwich Thammapalo 2, Wipawee Jampangern 3 and Kriengsak
More informationInnate immunity. Abul K. Abbas University of California San Francisco. FOCiS
1 Innate immunity Abul K. Abbas University of California San Francisco FOCiS 2 Lecture outline Components of innate immunity Recognition of microbes and dead cells Toll Like Receptors NOD Like Receptors/Inflammasome
More informationHepatitis C in Australia:
Hepatitis C in Australia: Epidemiology and Clinical Presentation (and a bit of virology ) A/Prof Mark Douglas Hepatitis C - Distribution Te and Jensen 2010 Clin Liver Dis Hepatitis C Epidemiology Estimated
More informationSubstitution or deletion mutations between nt 54 and 70 in the 59 non-coding region of dengue type 2 virus produce variable effects on virus viability
Journal of General Virology (2007), 88, 1748 1752 DOI 10.1099/vir.0.82455-0 Short Communication Correspondence Vijittra Leardkamolkarn scvlk@mahidol.ac.th Substitution or deletion mutations between nt
More informationFlavivirus Vaccines Japanese Encephalitis and Dengue
Flavivirus Vaccines Japanese Encephalitis and Dengue 14 th Advanced Vaccinology Course Veyrier du Lac, France May 16, 2012 Harold S. Margolis, MD Dengue Branch Centers for Disease Control and Prevention
More information8 THE ANTISEPTIC MONIKA MAHESHWARI, YAD RAM YADAV ABSTRACT. Introduction
The Study of Serum Aminotransferase Levels in Dengue Fever and it s Correlation with Clinical Profile MURLIDHAR, SARVESHWAR SHARAN DADHICH, MANGESH BORKAR, SANJIV MAHESHWARI, MONIKA MAHESHWARI, YAD RAM
More information1. Introduction. Dengue is a major medical and public health problem in tropical and subtropical regions. It is estimated that approximately
BioMed Research International Volume 213, Article ID 965853, 7 pages http://dx.doi.org/1.1155/213/965853 Clinical Study Increased Production of Interleukin-4, Interleukin-1, and Granulocyte-Macrophage
More informationFluid movement in capillaries. Not all fluid is reclaimed at the venous end of the capillaries; that is the job of the lymphatic system
Capillary exchange Fluid movement in capillaries Not all fluid is reclaimed at the venous end of the capillaries; that is the job of the lymphatic system Lymphatic vessels Lymphatic capillaries permeate
More informationCytokines (II) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel:
Cytokines (II) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa Learning Objectives By the end of this lecture you will be able to: 1 Understand the physiological
More informationIMMUNE SYSTEM. Biology 2201
IMMUNE SYSTEM Biology 2201 What is a disease? Other than an injury, any change in the body that interferes with the normal functioning of the body. Two Types of Diseases Non-infectious often called functional
More informationIMMUNE SYSTEM. Biology What is a disease? Other than an injury, any change in the body that interferes with the normal functioning of the body.
IMMUNE SYSTEM Biology 2201 What is a disease? Other than an injury, any change in the body that interferes with the normal functioning of the body. 1 Two Types of Diseases Non-infectious often called functional
More informationRisk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand
Tropical Medicine and International Health volume 9 no 9 pp 1022 1029 september 2004 Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic
More informationDetection of dengue virus genome in urine by real-time RT-PCR: a laboratory diagnostic method useful after disappearance of the genome in. serum.
JCM Accepts, published online ahead of print on 21 March 2012 J. Clin. Microbiol. doi:10.1128/jcm.06557-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Major Article Detection
More informationA Review on the Potential Therapeutic Profile of Carica papaya Leaf Extract in the Management of Dengue Fever - DR. PRADEEP B. E.
A Review on the Potential Therapeutic Profile of Carica papaya Leaf Extract in the Management of Dengue Fever - DR. PRADEEP B. E. POST GRADUATE DEPARTMENT OF PHARMACOLOGY, J.J.M.MEDICAL COLLEGE, DAVANGERE
More informationNature Medicine: doi: /nm.4322
1 2 3 4 5 6 7 8 9 10 11 Supplementary Figure 1. Predicted RNA structure of 3 UTR and sequence alignment of deleted nucleotides. (a) Predicted RNA secondary structure of ZIKV 3 UTR. The stem-loop structure
More informationImmunodeficiencies HIV/AIDS
Immunodeficiencies HIV/AIDS Immunodeficiencies Due to impaired function of one or more components of the immune or inflammatory responses. Problem may be with: B cells T cells phagocytes or complement
More informationTransplantation. Immunology Unit College of Medicine King Saud University
Transplantation Immunology Unit College of Medicine King Saud University Objectives To understand the diversity among human leukocyte antigens (HLA) or major histocompatibility complex (MHC) To know the
More informationSUMMARY AND CONCLUSIONS
SUMMARY AND CONCLUSIONS 6.1 SUMMARY Dengue virus (DENV) is a mosquito-borne flavivirus and the most prevalent arbovirus affecting the tropical and subtropical regions of the world and causing serious morbidity
More informationEpisode of coexisting infections with multiple dengue virus serotypes in central Karnataka, India
Journal of Infection and Public Health (2013) 6, 302 306 Episode of coexisting infections with multiple dengue virus serotypes in central Karnataka, India C.S. VinodKumar a,, N.K. Kalapannavar b, K.G.
More informationReceived 26 September 2009/Returned for modification 29 October 2009/Accepted 18 December 2009
CLINICAL AND VACCINE IMMUNOLOGY, Mar. 2010, p. 402 407 Vol. 17, No. 3 1556-6811/10/$12.00 doi:10.1128/cvi.00396-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. Discrepancy in
More informationHuman Immunodeficiency Virus
Human Immunodeficiency Virus Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Viruses and hosts Lentivirus from Latin lentis (slow), for slow progression of disease
More informationNOTES: CH 43, part 2 Immunity; Immune Disruptions ( )
NOTES: CH 43, part 2 Immunity; Immune Disruptions (43.3-43.4) Activated B & T Lymphocytes produce: CELL-MEDIATED IMMUNE RESPONSE: involves specialized T cells destroying infected host cells HUMORAL IMMUNE
More informationINTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE IMPACT OF DENGUE VIRUS ON INNATE AND ADAPTIVE IMMUNE SYSTEM AMIT GUPTA, SUSHAMA R CHAPHALKAR Department of Immunology, Vidya Pratishthan
More informationBioinformation by Biomedical Informatics Publishing Group
Predicted RNA secondary structures for the conserved regions in dengue virus Pallavi Somvanshi*, Prahlad Kishore Seth Bioinformatics Centre, Biotech Park, Sector G, Jankipuram, Lucknow 226021, Uttar Pradesh,
More informationCenters for Disease Control and Prevention Zika Diagnosis: Challenges and Opportunities
Centers for Disease Control and Prevention Zika Diagnosis: Challenges and Opportunities Jorge L. Muñoz-Jordán, Ph.D. Chief, Surveillance and Research Laboratory Centers for Disease Control and Prevention
More informationSection Lectures: Immunology/Virology Time: 9:00 am 10:00 am LRC 105 A & B
Section Director: Cliff Bellone, Ph.D. Office: Doisy Hall - R 405 Phone: 577-8449 E-Mail: bellonec@slu.edu Lecturers: James Swierkosz, Ph.D. Office: Medical School Rm. 412 Phone: 577-8430 E-Mail: swierkoszje@slu.edu
More informationGenus Ebolavirus is 1 of 3 members of the Filoviridae family (filovirus), along with genus Marburgvirus and genus Cuevavirus.
EBOLA VIRUS Ebola virus disease (EVD) is a severe, often fatal illness, with a case fatality rate of up to 90%. It is one of the world s most virulent diseases.the infection is transmitted by direct contact
More informationUsa Thisyakorn and Chule Thisyakorn
DENGUE: PITFALLS IN DIAGNOSIS AND MANAGEMENT Usa Thisyakorn and Chule Thisyakorn Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Abstract. Dengue is a mosquito-borne
More informationThe Ebola Virus. By Emilio Saavedra
The Ebola Virus By Emilio Saavedra Etiological Agents: Ebolavirus is the etiologic agent. [1] There are four main families of viruses that are agents of Ebola (hemorrhagic fever). [1] These four families
More informationVIRAL AGENTS CAUSING GASTROENTERITIS
VIRAL AGENTS CAUSING GASTROENTERITIS VIRAL AGENTS CAUSING GASTROENTERITIS Pathogens discussed in our lectures 1. Rotavirus 2. Enteric adenoviruses 3. Caliciviruses 4. Astroviruses 5. Toroviruses Viruses
More informationReport of Four Volunteers with Primary, Secondary and Tertiary Dengue Infections during a Prospective Cohort Study
Report of Four Volunteers with Primary, Secondary and Tertiary Dengue Infections during a Prospective Cohort Study Herman Kosasih a, Hadi Yusuf b, Primal Sudjana b, Bachti Alisjahbana b, Suharyono Wuryadi
More informationUpdated Questions and Answers related to the dengue vaccine Dengvaxia and its use
WHO Secretariat Updated Questions and Answers related to the dengue vaccine Dengvaxia and its use Published 22 December 2017 This document takes into account new and unpublished data that were communicated
More informationMyelitis= inflammation of the spinal cord
Polio infection 1 Illustrate the epidemiology of the disease 2 Demonstrate the clinical features of polio infection 3 Enumerate the complications 4 Prevent and treat polio infection MUMPS 1 Identify the
More informationDengue: The next vaccine preventable disease? Prof John McBride James Cook University
Dengue: The next vaccine preventable disease? Prof John McBride James Cook University Dengue viruses A flavivirus ~11kb genome, ~50nm diameter, lipid envelope. Gene order 5 C-prM-E-NS1 Four serotypes (1-4)
More informationELISA as an alternative tool for epidemiological surveillance for dengue in mosquitoes: a report from Thailand
J Vector Borne Dis 44, December 2007, pp. 272 276 ELISA as an alternative tool for epidemiological surveillance for dengue in mosquitoes: a report from Thailand Mayuna Srisuphanunt a, Ratana Sithiprasasna
More informationDynamics of lentiviral infection in vivo in the absence of adaptive immune responses
Dynamics of lentiviral infection in vivo in the absence of adaptive immune responses Elissa J. Schwartz Associate Professor School of Biological Sciences Department of Mathematics & Statistics Washington
More information